Company profile
New Path Molecular
New Path Molecular Research Ltd is a UK company with status active founded in 2015 based in East of England.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQzMjc3OTYyNmFkaXF6a2N4
Published 20 Aug 2024 17:05
Company registered at Companies House
New Path Molecular Research provides research services for flow chemistry projects.
New Path is chemistry driven: no biological mechanism has an impact on human health until a molecule is discovered to disrupt it It brings the best and most innovative chemistry to lanthipeptide discovery with a focus on drug resistant gram-negative bacteria and cancer therapy. They believe the impact that can be made by the best, most creative chemists, supported by the most sophisticated machine assisted chemistry tools has yet to be explored.
Too early to say as yet.
1 May 2025 to 31 Oct 2026
Pancreatic cancer (PDAC) patients face a lack of effective treatments, severe side effects from existing treatments and prolonged hospital stays, with limited impact on life expectancy. Globally, around 500,000 people are diagnosed annually (9,600 in UK), and this is expected to rise by 65% by 2040, one of the few cancers which is increasing in prevalence...
1 May 2024 to 28 Feb 2025
Pancreatic cancer (PDAC) patients face a lack of effective treatments, severe side effects from existing treatments and prolonged hospital stays, with limited impact on life expectancy. Globally, around 500,000 people are diagnosed annually (9,600 in UK), and this is expected to rise by 65% by 2040, one of the few cancers which is increasing in prevalence...
